FI942442A - Proteiinien tuotto 7B2-proteiinia käyttäen - Google Patents
Proteiinien tuotto 7B2-proteiinia käyttäen Download PDFInfo
- Publication number
- FI942442A FI942442A FI942442A FI942442A FI942442A FI 942442 A FI942442 A FI 942442A FI 942442 A FI942442 A FI 942442A FI 942442 A FI942442 A FI 942442A FI 942442 A FI942442 A FI 942442A
- Authority
- FI
- Finland
- Prior art keywords
- protein
- pct
- expressing
- vivo
- sec
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000338 in vitro Methods 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 108010006519 Molecular Chaperones Proteins 0.000 abstract 1
- 238000004220 aggregation Methods 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 238000010353 genetic engineering Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000003248 secreting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4722—G-proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9102009A NL9102009A (nl) | 1991-11-29 | 1991-11-29 | Produktie van bioactieve peptiden met recombinante cellen. |
PCT/EP1992/002740 WO1993011248A1 (en) | 1991-11-29 | 1992-11-27 | Production of proteins using 7b2 protein |
Publications (2)
Publication Number | Publication Date |
---|---|
FI942442A0 FI942442A0 (fi) | 1994-05-25 |
FI942442A true FI942442A (fi) | 1994-07-25 |
Family
ID=19859984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI942442A FI942442A (fi) | 1991-11-29 | 1994-05-25 | Proteiinien tuotto 7B2-proteiinia käyttäen |
Country Status (11)
Country | Link |
---|---|
US (2) | US5708140A (fi) |
EP (1) | EP0614490B1 (fi) |
JP (1) | JPH07501448A (fi) |
AT (1) | ATE174629T1 (fi) |
AU (1) | AU675919B2 (fi) |
CA (1) | CA2123567A1 (fi) |
DE (1) | DE69227921D1 (fi) |
FI (1) | FI942442A (fi) |
HU (1) | HUT67739A (fi) |
NL (1) | NL9102009A (fi) |
WO (1) | WO1993011248A1 (fi) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025681A1 (en) * | 1992-06-11 | 1993-12-23 | New York University | A cytoplasmic chaperonin and methods of making and using it |
US5474914A (en) * | 1992-07-29 | 1995-12-12 | Chiron Corporation | Method of producing secreted CMV glycoprotein H |
WO1994008012A1 (en) * | 1992-10-02 | 1994-04-14 | Research Corporation Technologies, Inc. | Methods for increasing secretion of overexpressed proteins |
GB9223816D0 (en) | 1992-11-13 | 1993-01-06 | Medical Res Council | Heat shock proteins and the treatment of tumours |
US5688651A (en) * | 1994-12-16 | 1997-11-18 | Ramot University Authority For Applied Research And Development Ltd. | Prevention of protein aggregation |
JPH09173078A (ja) * | 1995-09-14 | 1997-07-08 | Tadayuki Imanaka | 分子シャペロンを用いる蛋白質の製造方法 |
JP2000512487A (ja) * | 1996-05-14 | 2000-09-26 | スミスクライン・ビーチャム・コーポレイション | 新規化合物 |
US7569660B1 (en) | 1999-06-09 | 2009-08-04 | The University Of Chicago | Recombinant prion-like proteins and materials comprising same |
AU2001261242B2 (en) * | 2000-05-03 | 2006-12-14 | Expressive Constructs, Inc. | A method for improving recombinant protein stability and solubility |
JP4528460B2 (ja) * | 2000-06-30 | 2010-08-18 | 株式会社東芝 | 半導体素子 |
US20040138116A1 (en) * | 2002-08-30 | 2004-07-15 | Vincent Geenen | Tolerogenic approach for type 1 diabetes |
WO2005004894A2 (en) * | 2003-05-12 | 2005-01-20 | Expressive Constructs, Inc. | Methods for increasing cell and tissue viability |
US20050261475A1 (en) * | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
FR3008713B1 (fr) * | 2013-07-18 | 2016-11-25 | Commissariat Energie Atomique | Procede d'extraction et de purification d'acides nucleiques et tampons mis en œuvre |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8702590A (nl) * | 1987-10-30 | 1989-05-16 | Stichting Katholieke Univ | Eiwit 7b2 alsmede recombinant dna en cdna, mrna, en antilichamen voor 7b2 en werkwijze voor het detecteren van 7b2. |
CA1340740C (en) * | 1987-12-08 | 1999-09-14 | Eileen R. Mulvihill | Co-expression in eukaryotic cells |
-
1991
- 1991-11-29 NL NL9102009A patent/NL9102009A/nl not_active Application Discontinuation
-
1992
- 1992-11-27 DE DE69227921T patent/DE69227921D1/de not_active Expired - Lifetime
- 1992-11-27 HU HU9401604A patent/HUT67739A/hu unknown
- 1992-11-27 AT AT92923809T patent/ATE174629T1/de not_active IP Right Cessation
- 1992-11-27 CA CA002123567A patent/CA2123567A1/en not_active Abandoned
- 1992-11-27 WO PCT/EP1992/002740 patent/WO1993011248A1/en active IP Right Grant
- 1992-11-27 US US08/244,492 patent/US5708140A/en not_active Expired - Fee Related
- 1992-11-27 EP EP92923809A patent/EP0614490B1/en not_active Expired - Lifetime
- 1992-11-27 JP JP5509807A patent/JPH07501448A/ja active Pending
- 1992-11-27 AU AU29461/92A patent/AU675919B2/en not_active Ceased
-
1994
- 1994-05-25 FI FI942442A patent/FI942442A/fi unknown
-
1996
- 1996-09-09 US US08/709,915 patent/US5804417A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NL9102009A (nl) | 1993-06-16 |
ATE174629T1 (de) | 1999-01-15 |
DE69227921D1 (de) | 1999-01-28 |
US5804417A (en) | 1998-09-08 |
CA2123567A1 (en) | 1993-06-10 |
EP0614490A1 (en) | 1994-09-14 |
EP0614490B1 (en) | 1998-12-16 |
JPH07501448A (ja) | 1995-02-16 |
AU675919B2 (en) | 1997-02-27 |
US5708140A (en) | 1998-01-13 |
HUT67739A (en) | 1995-04-28 |
HU9401604D0 (en) | 1994-09-28 |
FI942442A0 (fi) | 1994-05-25 |
WO1993011248A1 (en) | 1993-06-10 |
AU2946192A (en) | 1993-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI942442A0 (fi) | Proteiinien tuotto 7B2-proteiinia käyttäen | |
DE69434447D1 (de) | Für die gentherapie verwendbare plasmide | |
DE69435096D1 (de) | Zusammensetzung zur in vivo erzeugung von therapeutischen produkten | |
DE69323879D1 (de) | Herstellung von rekombinanten, menschlichem lactoferrin | |
ATE117375T1 (de) | Transduktionsveränderte fibroblasten und ihre anwendung. | |
DE69410254T2 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
DE69432075T2 (de) | Intrazellulaere bindungs proteine und deren anwendungen | |
ES2193144T3 (es) | Compuestos de dna que comprenden secuencias que codifican manuronano c-5-epimerasa. | |
ATE246247T1 (de) | Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität | |
DK0688226T3 (da) | Proteinpræparat til forebyggelse og terapi af periodontitis eller andre bakterielle patologier i mundhulen | |
ATE175237T1 (de) | Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung. | |
NO971139D0 (no) | Fremgangsmåte for fremstilling av rekombinante proteiner, plasmider og modifiserte celler | |
AU669149B2 (en) | Expression signal-peptide-free staphylokinases | |
ATE315091T1 (de) | Modifizierte zellen auf der basis des betain- katabolismus, herstellung und verwendung insbesondere zur herstellung von metaboliten oder enzymen | |
ATE103989T1 (de) | Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung. | |
DE69132682T2 (de) | Zellwachstumsinhibitoren | |
DE69728654D1 (de) | Verwendung von il-7 zur behandlung von autoimmunkrankheiten, insbesondere insulinabhängigem diabetes mellitus | |
DE69133340D1 (de) | Neue type-i-interferon varianten, ihre verfahren zur herstellung, und ihre verwendungen | |
ATE123056T1 (de) | Ancrod-proteine, ihre herstellung und verwendung. | |
ATE265526T1 (de) | Genetisch veränderte fibroblasten und ihre verwendung | |
DE69434072D1 (de) | Regulierende nukleinsaeuresequenzen und verwendungen | |
ATE113314T1 (de) | Genetisch modifizierte milchsäurebakterien und ihre verwendung bei der herstellung von käse und rekombinanten plasmiden. | |
AU674909B2 (en) | New triazoloquinazolines, their production and their use | |
ATE124722T1 (de) | Für das plazentaprotein 9 (pp9) kodierende cdna, ihre isolierung und verwendung. | |
EP0374909A3 (de) | Für das Plazentaprotein 11 (PP11) kodierende cDNA, ihre Isolierung und Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: NOVARTIS AG |